Question at position 60 Why is it so difficult to develop treatments for prion diseases?The causative agent is a self-proteinIt is not a bacteriaMutations make vaccine development difficultAll of the aboveClear my selection

Question

BlackTom AI · Accepted Answer

Question at position 60 asks why it is so difficult to develop treatments for prion diseases. Each option is evaluated on its own merits and in relation to the overall challenge posed by prions.
Option 1: The causative agent is a self-protein. Prions are misfolded forms of a normal host protein (PrP) and operate without any nucleic acid. This self-protein nature means they can propagate by inducing misfolding of the normal protein, evading many conventional antimicrobial strategies that target foreign pathogens. This is a key reason treatments are challenging.
Option 2: It is not a bacteria. Prions are not bacteria or other microbes; they are proteinaceous infectious particles. This classification matters because many therapies target bacterial or viral features, and prions do not share those targets. Their non-self replication mechanism complicates drug design that relies on typical microbial biology.
Option 3: Mutations make vaccine development difficult. While prions lack nucleic acids, they exist in multiple strains distinguished by conformational differences of the PrP protein. These prion strains can yield different disease phenotypes and rates of progression, and antibodies or vaccines may fail to neutralize all strains uniformly. The absence of a stable genetic genome and the conformational diversity contribute to the difficulty in creating broadly effective interventions.
Option 4: All of the above. When considering the self-protein nature, non-bacterial identity, and strain/conformational variability that hinder immune targeting and drug effectiveness, the collective challenges described in the previous options indeed explain why treating prion diseases is particularly hard.

Question at position 60 Why is it so difficult to develop treatments for prion diseases?The causative agent is a self-proteinIt is not a bacteriaMutations make vaccine development difficultAll of the aboveClear my selection单项选择题

类似问题

Question at position 67 Which of the following is NOT a human PRION disease?Chronic Traumatic EncephalopathyKuruFatal Familial InsomniaCreutzfeldt-Jakob DiseaseClear my selection

Question at position 59 Which of the following is NOT a Transmissible Spongiform Encephalopathy (TSE)?KuruChronic Wasting DiseaseScrapieall are TSEsClear my selection

Question at position 49 The Kuru outbreak in Papua New Guinea was halted by:the imposition of a ban on a historical cultural practicethe eradication of a bat vectorproper sanitationthe development of a vaccineClear my selection

Question at position 31 Bovine spongiform encephalopathy is also known as:mad cow diseaseKurumad dog diseasecrazy cow diseaseClear my selection

What is a characteristic feature of the brain tissue in patients with Transmissible Spongiform Encephalopathies (TSEs)?

What was the world's first widely adopted biodiversity policy?

The aim of the Paris Agreement is to ensure that the earth’s preindustrial temperature is not exceeded by more than º Celsius.

The IPCC's mission is to Blank ______.

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单